losartan has been researched along with Dyspnea in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with idiopathic pulmonary fibrosis and a baseline %FVC of ≥50 % were treated with losartan 50 mg by mouth daily for 12 months." | 9.16 | Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. ( Couluris, M; Gross-King, M; Kinder, BW; Krischer, J; Panos, RJ; Xu, P, 2012) |
| "Patients with idiopathic pulmonary fibrosis and a baseline %FVC of ≥50 % were treated with losartan 50 mg by mouth daily for 12 months." | 5.16 | Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. ( Couluris, M; Gross-King, M; Kinder, BW; Krischer, J; Panos, RJ; Xu, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couluris, M | 1 |
| Kinder, BW | 1 |
| Xu, P | 1 |
| Gross-King, M | 1 |
| Krischer, J | 1 |
| Panos, RJ | 1 |
1 trial available for losartan and Dyspnea
| Article | Year |
|---|---|
Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project.
Topics: Aged; Aged, 80 and over; Disease Progression; Dyspnea; Exercise Test; Female; Humans; Idiopathic Pul | 2012 |